Para su Difusión
FTC Renews Challenge of More Than 200 Improper Patent Listings
Fecha
Continuing its efforts to promote competition and lower drug prices, today the Federal Trade Commission renewed its challenges against dozens of improperly listed device patents that shield brand-name...